Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
202 studies found for:    "Herpes Simplex"
Show Display Options
Rank Status Study
1 Completed
Has Results
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
Condition: Herpes Simplex
Interventions: Drug: Acyclovir;   Drug: Placebo
2 Completed Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-Positive Adults
Condition: Prophylaxis Herpes Simplex
Intervention: Biological: Herpes simplex candidate (gD) vaccine GSK208141
3 Completed Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without Adjuvant
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine GSK208141 - non-MPL-containing adjuvant;   Biological: Herpes simplex candidate vaccine GSK208141- MPL-containing adjuvant
4 Completed Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell Lines
Condition: Prophylaxis Herpes Simplex
Interventions: Biological: Adjuvanted herpes simplex (gD) candidate vaccine GSK 208141;   Biological: Herpes simplex virus containing gD-Alum
5 Completed Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Condition: Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK208141;   Biological: Placebo injection
6 Completed
Has Results
Pharmacokinetics, Acceptability and Safety of Famciclovir in Infants (1 Month to Less Than 12 Months) With Herpes Simplex Infection
Condition: Herpes Simplex
Intervention: Drug: famciclovir
7 Completed Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Condition: Herpes Simplex
Interventions: Biological: GSK208141;   Biological: HavrixTM (investigational formulation);   Biological: Placebo
8 Completed Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects
Condition: Prophylaxis for Herpes Simplex
Interventions: Biological: Herpes simplex candidate vaccine- adjuvanted GSK 208141;   Biological: Placebo
9 Completed Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine
Condition: Herpes Simplex
Intervention: Biological: GSK208141 vaccine
10 Completed Valaciclovir to Prevent Transmission of Herpes Simplex Virus
Condition: Herpes Simplex
Intervention: Drug: Valaciclovir
11 Completed
Has Results
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection
Condition: Herpes Simplex
Intervention: Drug: Famciclovir
12 Completed Open-label Study of ASP2151 in Herpes Simplex Patients
Condition: Herpes Simplex
Intervention: Drug: ASP2151
13 Completed Phase III Study of ASP2151 in Herpes Simplex Patients
Condition: Herpes Simplex
Interventions: Drug: ASP2151;   Drug: ASP2151 placebo
14 Unknown  Herpes Simplex Reactivation in Adult Critical Care Patients
Conditions: Herpes Simplex I;   Herpes Simplex II
Intervention: Other: No intervention will be performed
15 Recruiting Identification of Herpes Simplex Virus (HSV) Shedding in the Female Genital Tract of Pregnant and Nonpregnant Women by GeneXpert PCR, Routine PCR, and Culture
Condition: Herpes Simplex Virus
Intervention: Device: Genexpert assay
16 Completed Effectiveness of TheraNeem Lip Therapy for Herpes Simplex Labialis
Condition: Herpes Simplex
Intervention: Other: Neem Based External Application Cream
17 Completed
Has Results
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia
Condition: Herpes Simplex
Intervention: Drug: acyclovir sodium
18 Completed
Has Results
Zinc for the Treatment of Herpes Simplex Labialis (HSL)
Condition: Herpes Simplex Labialis
Interventions: Drug: Zicam (Ionic zinc);   Drug: placebo
19 Withdrawn A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)
Condition: Herpes Simplex Virus
Interventions: Drug: Novel Antiviral Drug;   Drug: Placebo
20 Terminated The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis
Condition: Herpes Simplex Keratitis
Intervention: Procedure: Corneal sampling

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.